Release Date: 05/10/22 15:39 Summary: Board Changes at Breaker Resources Price Sensitive: Yes Download Document 130.5KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%